Department of Applied Mathematics, University of Washington, Seattle, Washington, United States of America.
Herbold Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
PLoS Comput Biol. 2022 Nov 4;18(11):e1010677. doi: 10.1371/journal.pcbi.1010677. eCollection 2022 Nov.
As a cancer develops, its cells accrue new mutations, resulting in a heterogeneous, complex genomic profile. We make use of this heterogeneity to derive simple, analytic estimates of parameters driving carcinogenesis and reconstruct the timeline of selective events following initiation of an individual cancer, where two longitudinal samples are available for sequencing. Using stochastic computer simulations of cancer growth, we show that we can accurately estimate mutation rate, time before and after a driver event occurred, and growth rates of both initiated cancer cells and subsequently appearing subclones. We demonstrate that in order to obtain accurate estimates of mutation rate and timing of events, observed mutation counts should be corrected to account for clonal mutations that occurred after the founding of the tumor, as well as sequencing coverage. Chronic lymphocytic leukemia (CLL), which often does not require treatment for years after diagnosis, presents an optimal system to study the untreated, natural evolution of cancer cell populations. When we apply our methodology to reconstruct the individual evolutionary histories of CLL patients, we find that the parental leukemic clone typically appears within the first fifteen years of life.
随着癌症的发展,其细胞会积累新的突变,从而导致异质性、复杂的基因组图谱。我们利用这种异质性,从驱动癌变的参数中得出简单、分析性的估计,并重建个体癌症起始后选择事件的时间线,其中有两个纵向样本可供测序。通过对癌症生长的随机计算机模拟,我们表明我们可以准确估计突变率、驱动事件发生前后的时间以及起始癌细胞和随后出现的亚克隆的生长速率。我们证明,为了获得突变率和事件时间的准确估计,应该对观察到的突变计数进行校正,以考虑肿瘤形成后发生的克隆突变以及测序覆盖度。慢性淋巴细胞白血病 (CLL) 在诊断后通常不需要多年治疗,因此是研究未经治疗的癌症细胞群体自然演变的最佳系统。当我们应用我们的方法重建 CLL 患者的个体进化史时,我们发现亲本白血病克隆通常出现在生命的头十五年内。